Home » SCOTUS “Pay-for-Delay” Decision Provides Roadmap for Case-by-Case Crackdown
SCOTUS “Pay-for-Delay” Decision Provides Roadmap for Case-by-Case Crackdown
“Pay-for-delay” deals between brand drugmakers and their generic competitors can sometimes violate antitrust law, the Supreme Court ruled Monday, issuing a tempered decision that will make it easier for legal challenges to be brought by critics of the practice.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May